Correlation Between Asure Software and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Asure Software and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Asure Software and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Asure Software and Abcellera Biologics, you can compare the effects of market volatilities on Asure Software and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Asure Software with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Asure Software and Abcellera Biologics.
Diversification Opportunities for Asure Software and Abcellera Biologics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Asure and Abcellera is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Asure Software and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Asure Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Asure Software are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Asure Software i.e., Asure Software and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Asure Software and Abcellera Biologics
Given the investment horizon of 90 days Asure Software is expected to generate 1.52 times less return on investment than Abcellera Biologics. But when comparing it to its historical volatility, Asure Software is 1.28 times less risky than Abcellera Biologics. It trades about 0.08 of its potential returns per unit of risk. Abcellera Biologics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 243.00 in Abcellera Biologics on September 5, 2024 and sell it today you would earn a total of 48.00 from holding Abcellera Biologics or generate 19.75% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Asure Software vs. Abcellera Biologics
Performance |
Timeline |
Asure Software |
Abcellera Biologics |
Asure Software and Abcellera Biologics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Asure Software and Abcellera Biologics
The main advantage of trading using opposite Asure Software and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Asure Software position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.Asure Software vs. Alkami Technology | Asure Software vs. Blackbaud | Asure Software vs. Enfusion | Asure Software vs. Clearwater Analytics Holdings |
Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |